Michael T. Constantino insider trades

Open-market stock purchases and sales by Michael T. Constantino, Director at Humacyte, Inc, from SEC Form 4 filings since Jul 6, 2020.

Track record: 25% of 8 scored buys are up 5% or more since purchase, averaging -51%.

Recent trades

DateStockTradeValue
Jun 11, 2026HUMA Humacyte, IncBought (not open market)—
May 18, 2026HUMA Humacyte, IncBought$9.8K

Companies traded

  • HUMA Humacyte, Inc: 8 buys, last Jun 11, 2026
  • NMTR 9 Meters Biopharma, Inc: 4 buys, last Mar 29, 2023

Get free alerts when Michael T. Constantino files a new trade →